NIH Consensus Development Conference
Management of
Hepatitis B
October 20–22, 2008
Bethesda, Maryland
Conference Home
Final Statement | PDF
Program & Abstracts | PDF
Archived Videocast Day 1 | 2 | 3
Evidence Report
Planning Committee | Panel
Additional Information
Documents in PDF format require the Adobe Acrobat Reader®.
If you experience problems with PDF documents, please download
the latest version of the Reader®.
Conference Scope
The Consensus Development panel assessed the evidence on the following conference questions:
- What is the current burden of hepatitis B?
- What is the natural history of hepatitis B?
- What are the benefits and risks of the current therapeutic options for hepatitis B?
- Which persons with hepatitis B should be treated?
- What measures are appropriate to monitor therapy and assess outcomes?
- What are the greatest needs and opportunities for future research on hepatitis B?
 |
Learn more about the NIH Consensus Development Program | |
| Join the Consensus Development Program Information Network | ||
 |
Contact us with any questions or comments | |
Kelli Marciel, Communications Director |
||
MarcielK@od.nih.gov | 301-496-4819 |
||
Contact Consensus Program |
Privacy Notice |
Disclaimer |
Accessibility |
Contact NIH
